Changes

no edit summary
Line 76: Line 76:  
|FQR
 
|FQR
 
|
 
|
|8/1/21 FQR deleted "'''This page is under construction'''
+
|
 
|-
 
|-
 
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
 
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
Line 114: Line 114:  
|FQR
 
|FQR
 
|
 
|
|8/1/21 FQR deleted "'''This page is under construction'''
+
|
 
|-
 
|-
 
|    Systemic Mastocytosis||Disease
 
|    Systemic Mastocytosis||Disease
Line 1,396: Line 1,396:  
|Emailed 28/3/2022 for progress update
 
|Emailed 28/3/2022 for progress update
 
|-
 
|-
|ALK-Positive Large B-cell Lymphoma||Disease||Nakasaki Manando
+
|ALK-Positive Large B-cell Lymphoma||Disease||Nakasaki Manando (fellow), Fabiola Quintero-Rivera
 
|
 
|
 
|
 
|
Line 1,402: Line 1,402:  
| ||GC
 
| ||GC
 
|
 
|
|Nakasaki Manando removed March 2022 due to no progress/contact 1y. Added Nakasaki Manando back n 8/29/22 based on newer email communication (Jennelle's note).  2021 template added.
+
|Nakasaki Manando removed March 2022 due to no progress/contact 1y. Added Nakasaki Manando back n 8/29/22 based on newer email communication (Jennelle's note).  2021 template added. FQR emailed Manando on 4/12/23
 
|-
 
|-
 
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
 
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera